受强制性开放获取政策约束的文章 - Ken Furudate了解详情
无法在其他位置公开访问的文章：1 篇
Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib
Y Sasaki, HM Kantarjian, NJ Short, F Wang, K Furudate, H Uryu, R Garris, ...
Leukemia 36 (5), 1253-1260, 2022
强制性开放获取政策： US National Institutes of Health, Cancer Prevention Research Institute of …
可在其他位置公开访问的文章：14 篇
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
K Morita, F Wang, K Jahn, T Hu, T Tanaka, Y Sasaki, J Kuipers, S Loghavi, ...
Nature communications 11 (1), 5327, 2020
强制性开放获取政策： US National Institutes of Health, Cancer Prevention Research Institute of …
Outcomes of TP53‐mutant acute myeloid leukemia with decitabine and venetoclax
K Kim, A Maiti, S Loghavi, R Pourebrahim, TM Kadia, CR Rausch, ...
Cancer 127 (20), 3772-3781, 2021
强制性开放获取政策： US National Institutes of Health
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms
AS Sperling, VA Guerra, JA Kennedy, Y Yan, JI Hsu, F Wang, AT Nguyen, ...
Blood, The Journal of the American Society of Hematology 140 (16), 1753-1763, 2022
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute, Cancer …
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia
F Wang, K Morita, CD DiNardo, K Furudate, T Tanaka, Y Yan, KP Patel, ...
Nature communications 12 (1), 2607, 2021
强制性开放获取政策： US National Institutes of Health, V Foundation, USA, Cancer Prevention …
Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax
CA Lachowiez, S Loghavi, K Furudate, G Montalban-Bravo, A Maiti, ...
Blood advances 5 (8), 2173-2183, 2021
强制性开放获取政策： US National Institutes of Health
Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study
CA Lachowiez, PK Reville, H Kantarjian, E Jabbour, G Borthakur, N Daver, ...
The Lancet Haematology 9 (5), e350-e360, 2022
强制性开放获取政策： US National Institutes of Health, V Foundation, USA
Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1‐mutated acute myeloid …
S Loghavi, CD DiNardo, K Furudate, K Takahashi, T Tanaka, NJ Short, ...
British journal of haematology 192 (6), 1054-1063, 2021
强制性开放获取政策： US National Institutes of Health
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia
N Baran, A Lodi, Y Dhungana, S Herbrich, M Collins, S Sweeney, ...
Nature communications 13 (1), 2801, 2022
强制性开放获取政策： US National Institutes of Health, Canadian Cancer Society, Canadian …
Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia
T Tanaka, K Morita, S Loghavi, F Wang, K Furudate, Y Sasaki, L Little, ...
Blood, The Journal of the American Society of Hematology 138 (18), 1733-1739, 2021
强制性开放获取政策： US National Institutes of Health, Cancer Prevention Research Institute of …
Contemporary outcomes in IDH‐mutated acute myeloid leukemia: The impact of co‐occurring NPM1 mutations and venetoclax‐based treatment
CA Lachowiez, PK Reville, H Kantarjian, E Jabbour, G Borthakur, N Daver, ...
American journal of hematology 97 (11), 1443-1452, 2022
强制性开放获取政策： V Foundation, USA
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity
M Schwede, K Jahn, J Kuipers, LA Miles, RL Bowman, T Robinson, ...
Leukemia, 1-10, 2024
强制性开放获取政策： Swiss National Science Foundation, Chan Zuckerberg Initiative
Overcoming NOTCH1-driven chemoresistance in T-cell acute lymphoblastic leukemia via metabolic intervention with oxphos inhibitor
N Baran, A Lodi, Y Dhungana, SR Sweeney, P Renu, S Herbrich, FW Hoff, ...
Blood 136, 18-20, 2020
强制性开放获取政策： US National Institutes of Health, German Research Foundation, Cancer …
CLL Cell-Derived Exosomes Impair Immune Function and Normal Hematopoiesis in CLL
I Veletic, DM Harris, U Rozovski, P Li, Z Liu, T Manshouri, MTS Bertilaccio, ...
Blood 142, 3264, 2023
强制性开放获取政策： US National Institutes of Health
Single-Cell Proteogenomics Analysis of AML Samples Treated with Decitabine and Venetoclax Reveals Divergent Treatment Escape Mechanisms
YJ Kim, Z Li, A Maiti, T Tanaka, H Uryu, K Furudate, K Hayes, N Daver, ...
Blood 142, 2931, 2023
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定